Archon Biosciences emerges from stealth with $20M to create tiny ‘Antibody Cages’
GeekWire
OCTOBER 30, 2024
We can make two drugs for two different applications, and make it easier to do both.” They licensed the AbC technology from UW and incorporated Archon Biosciences in 2023. Taking aim at cancer Archon is already focusing in on its first therapeutic applications, most likely including cancer treatment. ” .
Let's personalize your content